Isolated renal mucormycosis masquerading as emphysematous pyelonephritis

被引:2
作者
Narayanaswamy, Supradeep [1 ]
Goradia, Rajvi [2 ]
Bellurkar, Amit [2 ]
Patwardhan, Sujata [2 ]
机构
[1] Seth GS Med Coll & KEM Hosp, Mumbai, Maharashtra, India
[2] Seth GS Med Coll & KEM Hosp, Urol, Mumbai, Maharashtra, India
关键词
urinary tract infections; drugs misuse (including addiction); urological surgery; urology;
D O I
10.1136/bcr-2022-254501
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mucormycosis is an acute, life-threatening infection and isolated renal involvement is rare. Due to the angioinvasive nature of the disease, it is rapidly progressive and can be lethal if not managed expeditiously. In patients with underlying conditions of immunosuppression, diabetes mellitus, transplantation, COVID-19, intravenous drug and substance use and pyelonephritis, which is unable to be controlled via regular antibiotics, mucormycosis must be considered on the differential and antifungals must be empirically started. Most cases are often diagnosed on histopathology, which causes delayed treatment and resolution. We present a case of emphysematous pyelonephritis diagnosed on imaging and was later found to have mucormycosis on histopathological examination.
引用
收藏
页数:4
相关论文
共 9 条
[1]  
[Anonymous], 2001, INDIAN J NEPHROL, V11, P147
[2]   Can Ascending Infection from Bladder Serve as the Portal of Entry for Primary Renal Zygomycosis? [J].
Gupta, Kirti ;
Nada, Ritambhra ;
Joshi, Kusum ;
Rohilla, Minakshi ;
Walia, Rama .
MYCOPATHOLOGIA, 2010, 170 (05) :357-360
[3]  
Guymer Chelsea, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-009577
[4]  
INGRAM CW, 1989, REV INFECT DIS, V11, P741
[5]   Primary renal mucormycosis [J].
Lussier, N ;
Laverdière, M ;
Weiss, K ;
Poirier, L ;
Schick, E .
UROLOGY, 1998, 52 (05) :900-903
[6]   Infectious risks associated with medicinal Cannabis: Potential implications for immunocompromised patients? [J].
McHardy, Ian ;
Romanelli, Anna ;
Harris, Linda J. ;
Opp, Glenn ;
Gaudino, Reggie ;
Torres, Anthony ;
Polage, Christopher R. ;
Tuscano, Joseph M. ;
Thompson, George R., III .
JOURNAL OF INFECTION, 2018, 76 (05) :500-501
[7]   Novel perspectives on mucormycosis: Pathophysiology, presentation, and management [J].
Spellberg, B ;
Edwards, J ;
Ibrahim, A .
CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (03) :556-+
[8]   Recent advances in the treatment of mucormycosis [J].
Spellberg B. ;
Ibrahim A.S. .
Current Infectious Disease Reports, 2010, 12 (6) :423-429
[9]  
Verma R, 2011, BASIC APPL PATHOLOGY, V4, P66, DOI DOI 10.1111/J.1755-9294.2011.01102.X